Artelo Biosciences, Inc. (ARTL)
5.42
-0.25
(-4.41%)
USD |
NASDAQ |
Apr 14, 15:31
Artelo Biosciences Cash from Investing (TTM) : -0.0639M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -0.034M |
| GlucoTrack, Inc. | -0.096M |
| Ovid Therapeutics, Inc. | -49.85M |
| Apellis Pharmaceuticals, Inc. | -0.313M |
| Gossamer Bio, Inc. | 156.36M |